scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1090535892 |
P356 | DOI | 10.1038/S41598-017-05411-Z |
P932 | PMC publication ID | 5506018 |
P698 | PubMed publication ID | 28698595 |
P2093 | author name string | Heng Zhang | |
Zhi-Wei Li | |||
Ying-Xue Li | |||
Jun-Feng Zhu | |||
Wei-Jun Peng | |||
Chun-Hua Zhang | |||
Wei-Rong Yan | |||
Hai-Hong Di | |||
Xian-Ping Shen | |||
P2860 | cites work | A molecular variant of angiotensinogen associated with preeclampsia | Q24309422 |
Association of maternal AGTR1 polymorphisms and preeclampsia: a systematic review and meta-analysis | Q26828906 | ||
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology | Q26865332 | ||
The control of the false discovery rate in multiple testing under dependency | Q29032132 | ||
A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting | Q32074789 | ||
Pre-eclampsia part 1: current understanding of its pathophysiology | Q33416340 | ||
A hybrid design: case-parent triads supplemented by control-mother dyads | Q33644520 | ||
Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia | Q33654741 | ||
Distortion of maternal-fetal angiotensin II type 1 receptor allele transmission in pre-eclampsia. | Q33681074 | ||
Genetic aspects of preeclampsia and the HELLP syndrome. | Q33766563 | ||
The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes | Q33769295 | ||
The use of case-parent triads to study joint effects of genotype and exposure | Q34146147 | ||
Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis | Q34205648 | ||
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels | Q34262228 | ||
Investigation of maternal effects, maternal-fetal interactions and parent-of-origin effects (imprinting), using mothers and their offspring | Q34511692 | ||
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis | Q34708320 | ||
Diagnosis and management of gestational hypertension and preeclampsia | Q35173115 | ||
Induction of heme oxygenase-1 shifts the balance from proinjury to prosurvival in the placentas of pregnant rats with reduced uterine perfusion pressure | Q35850254 | ||
The role of RAS in the pathogenesis of preeclampsia | Q36467563 | ||
The functional role of the renin-angiotensin system in pregnancy and preeclampsia | Q37039872 | ||
Preeclampsia risk and angiotensinogen polymorphisms M235T and AGT -217 in African American and Caucasian women | Q37175181 | ||
Preeclampsia and future maternal health | Q37751739 | ||
Meta analysis of angiotensin-converting enzyme I/D polymorphism as a risk factor for preeclampsia in Chinese women | Q38015262 | ||
Angiotensin II type I receptor A1166C polymorphism increases the risk of pregnancy hypertensive disorders: Evidence from a meta-analysis | Q38065919 | ||
Functional and genetic studies of the angiotensin II type 1 receptor in pre-eclamptic and normotensive pregnant women. | Q38340110 | ||
The renin-angiotensin system and its involvement in vascular disease | Q38490314 | ||
Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. | Q41210828 | ||
Maternal and fetal angiotensin-converting enzyme gene insertion/deletion polymorphism not associated with pregnancy-induced hypertension in Chinese women | Q44307869 | ||
ACE I/D and G2350A polymorphisms in Pakistani hypertensive population of Punjab | Q44620017 | ||
Prediction of preeclampsia: liver function tests during the first 20 gestational weeks | Q44840235 | ||
Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin-converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women | Q45007339 | ||
Molecular basis of human hypertension: role of angiotensinogen | Q45118696 | ||
Are most maternal deaths from pre-eclampsia avoidable? | Q46325585 | ||
Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes | Q46340423 | ||
Impact of interaction of cigarette smoking with angiotensin-converting enzyme polymorphisms on end-stage renal disease risk in a Han Chinese population | Q46533154 | ||
Genetic and environmental factors associated with the development of hypertension in pregnancy | Q47605160 | ||
Liver function tests in preeclampsia. | Q48874822 | ||
Angiotensin-converting enzyme insertion/deletion (ACE I/D) and angiotensin II type 1 receptor (AT1R) gene polymorphism and its association with preeclampsia in Chinese women. | Q51465263 | ||
Likelihoods and TDT for the case-parents design. | Q52910008 | ||
AGT M235T polymorphism contributes to risk of preeclampsia: evidence from a meta-analysis. | Q53098465 | ||
Pre-eclampsia | Q56019568 | ||
Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis | Q56893651 | ||
Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
Measured Haplotype Analysis of the Angiotensin-I Converting Enzyme Gene | Q57377961 | ||
Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: A population-based Swedish cohort study | Q57697489 | ||
The upregulation of angiotensin II receptor AT1 in human preeclamptic placenta | Q58029863 | ||
Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia | Q59367444 | ||
The association of AGTR2 polymorphisms with preeclampsia and uterine artery bilateral notching is modulated by maternal BMI | Q59546012 | ||
Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen | Q71695937 | ||
A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease | Q72541490 | ||
Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries | Q73556747 | ||
Case-parents design for gene-environment interaction | Q74651316 | ||
Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua | Q77893110 | ||
The M235T variant of the angiotensinogen gene and the body mass index are useful markers for prevention of hypertension in pregnancy: a tree-based analysis of gene-environment interaction | Q78819837 | ||
Combining the transmission disequilibrium test and case-control methodology using generalized logistic regression | Q80513267 | ||
Maternal/newborn genotype contribution of the renin-angiotensin system (Met235Thr, Thr174Met, I/D-ACE, A2350G-ACE, A1166C-AT2R1, C3123A- AT2R2, 83A/G-REN) to the risk of pre-eclampsia: a Romanian study | Q83706578 | ||
Association of angiotensin II type 1-receptor gene polymorphisms with the risk of developing hypertension in Mexican individuals | Q84776097 | ||
Polymorphisms in angiotensin-converting enzyme and glutathione s-transferase genes in Turkish population and risk for preeclampsia | Q86209765 | ||
Effect of an educational intervention on cardiovascular disease risk perception among women with preeclampsia | Q87422818 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pre-eclampsia | Q61335 |
P304 | page(s) | 5087 | |
P577 | publication date | 2017-07-11 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | The Gene Variants of Maternal/Fetal Renin-Angiotensin System in Preeclampsia: A Hybrid Case-Parent/Mother-Control Study | |
P478 | volume | 7 |
Search more.